Tailored Enteral Nutrition for Hepatic Patients

Fresubin^® HEPA is a 1.3 kcal/ml product developed for patients with acute and chronic liver failure, including those at risk of hepatic encephalopathy.

A healthcare professional speaks with a patient in hospital as their nutritional needs are supported by Fresubin HEPA, a tube feed developed for patients with acute and chronic liver failure.

Tailored Enteral Nutrition for Hepatic Patients

Formulated to Address the Specific Demands of Hepatic Metabolism

Fresubin HEPA* is formulated with an adapted amino acid profile, sodium and volume adjusted in line with recommendations for hepatic patients, and a fat profile designed to support digestion and tolerance.^1-6

Nutritionally complete and clinically free from lactose and gluten, it is suitable as a sole source of nutrition under medical supervision in patients with acute and chronic liver failure.

Adapted Amino Acid Profile

Provides 44% of protein as branched-chain amino acids (BCAA) to address the altered amino acid metabolism in patients with hepatic encephalopathy.^1-3

Sodium and Volume Adapted to Hepatic Needs

Sodium content and volume are adapted in line with recommendations for hepatic patients, and those presenting with ascites and oedema.^4,5

Adapted Fat and Fibre Profile

With medium chain triglycerides (MCT) comprising 35% of fat for easy absorption⁶, alongside fibre to help maintain gut physiology.⁷

When to Consider Fresubin HEPA

Patients with acute or chronic liver failure frequently present with altered amino acid metabolism, fluid retention and increased malnutrition risk, requiring an enteral formula specifically adapted to their nutritional needs.^1-5

Fresubin HEPA is particularly suited to patients with hepatic encephalopathy, ascites or oedema, where standard enteral formulas may not adequately address their specific metabolic and nutritional demands.^1-5

An older man sits with a healthcare professional alongside Fresubin HEPA, which is formulated to address the specific metabolic and nutritional demands of hepatic patients.

Ready to Use in Clinical Practice

Fresubin HEPA comes as a ready-to-use tube feed in a 500 ml EasyBag.

Tube Size:
• Pump-assisted feeding: ≥ CH 8
• Gravity feeding: ≥ CH 12

Complete Nutrition: ≥ 1500ml (1950 kcal)/day

Dosage: To be determined by the responsible healthcare professional based on individual patient requirements.

Fresubin® ONS

Discover our wide range of Oral Nutritional Supplements.

Fresubin® Tube Feeds

Explore Fresubin®'s Tube Feed Ranges.

Fresubin HEPA factsheets can be downloaded here:

Fresubin HEPA Factsheet

Filename: Fresubin_Hepa_FS_HCP_Dec2022.pdf
Size: 1 MB
Format: pdf

Fresubin HEPA Drink Factsheet

Filename: Fresubin_HepaDrink_FS_HCP_Dec2022.pdf
Size: 301 KB
Format: pdf

*Fresubin HEPA products are food for special medical purposes, to be used under medical supervision. For the dietary management of patients with or at risk of malnutrition.Suitable as sole source of nutrition. Not suitable for children under 3 years or patients with galactosaemia. Use with caution in children under 6 years. Not for parenteral (I.V.) use. For Healthcare Professionals only.

References:

1 Amodio P et al. Hepatology. 2013;58(1):325-36.
2 Gluud LL et al. 2017;5(5):CD001939.
3 Bischoff SC et al. Clin Nutr. 2020;39(12):3533-3562
4 European Association for the Study of the Liver. J Hepatol. 2019;70(1):172-193.
5 European Association for the Study of the Liver. J Hepatol. 2018;69(2):406-460.
6 Babayan VK. Lipids. 1987;22(6):417-20.
7 Lochs H et al. Clin Nutr. 2006;25(2):180-6.